Inside IC System’s Successful Partnership with Genomind

 

Finding a perfect match can be difficult, but sometimes things just click. That’s the case with IC System and Genomind.

Genomind, a company utilizing genetics as a data point in diagnosing mental health challenges, wanted a recovery agency that, instead of aggressively going after those who hadn’t yet paid for the services provided, would take a tactful approach.

“We didn’t set any goals other than we didn’t want patients to be upset and didn’t want them to call the doctors and upset the doctors, which would cascade into them calling our sales reps,” said Thomas Hess, Senior Vice President and Chief Financial Officer of Genomind. “We had zero expectations for collections. Our goal was just not to upset people.”

Genomind had chatted with other companies in the same space as IC System and ran a pilot with IC once Hess found the IC System website and was impressed with the transparency, family-oriented nature of the business and site design.

Rather than simply not upsetting people, Genomind found a success rate that far outpaced their goals, leading to millions of dollars added in revenue and recovery.

Genomind was an ideal client for IC System, said Bryan Campbell, Business Development Manager, since IC System is always happy to modify its approach and work with each client on an individual basis.

The partnership looked a bit different during the pandemic, but the companies were able to come together using virtual meeting platforms to make sure everyone was reaching their goals.

“Everybody’s doing the same thing, but we at IC System, from a sales standpoint, say that everybody is operating at the same way. You’ve got to do it better,” he said. “You have to build those relationships and make sure those carry through in a new way and stronger way.

“We just got after that. They were real treats to able to get on, to use the new technology and depend on it rather than just being on the phone. It’s like we haven’t missed a beat.”

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

weekly drive-in
Metropolis: Weekly Drive-in
April 15, 2026

Metropolis “Weekly Drive In” reflects a new era of storytelling where AI meets real-world execution, turning everyday field performance into momentum. Centered on genuine conversions and local wins, the series highlights how the company is scaling not just through technology, but through visibility and shared recognition. In an emerging recognition economy, these updates act…

Read More
Drive In, Drive Out: The Rhythm of Metropolis
April 15, 2026

Behind the seemingly mundane choreography of a drive-in lies a broader story about how modern cities script behavior, turning even the simplest actions into rehearsed routines. What looks like repetition is really a quiet testament to systems designed for flow and control, where efficiency often outweighs individuality. In places like Metropolis, the rhythm of…

Read More
telemetry
Visibility at Scale: How Data, Telemetry, and IT Architecture Enable High-Performance Data Centers
April 14, 2026

As AI infrastructure scales at an unprecedented pace, the complexity of managing data center operations has shifted from purely physical challenges to deeply digital ones. Today’s facilities generate enormous volumes of telemetry, and industry estimates suggest hyperscale and AI data centers produce millions of data points per second. At that scale, visibility is no…

Read More
healthcare
The Early-Stage Playbook for Healthcare Founders: Credibility, Founder Mindset, and Real Market Fit
April 13, 2026

Healthcare innovation is having a moment. With over 500 startups applying annually to leading accelerators like Health Wildcatters, the sector is seeing a surge of founders eager to tackle inefficiencies in care delivery, diagnostics, and patient experience. At the same time, digital health is regaining momentum—after a period of market correction, funding went up…

Read More